atrial fibrillation
Conditions
Interventions
Control Group:conventional treatment: Oral amiodarone, rivaroxaban, or dabigatran for 3 months, proton pump inhibitors for 1 month
Treatment Group:On the basis of conventional treatment in Western medicine add Yiqi Yangyin Ding Ji traditional Chinese medicine Qiposhengmai granules
Sponsors
Dongzhimen Hospital Beijing University of Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: (1) Meet the diagnostic criteria for atrial fibrillation. (2) Patients undergoing their first radiofrequency ablation procedure. (3) Meet the diagnostic criteria for the Traditional Chinese Medicine syndrome of palpitations and deficient Yin and Qi. (4) Aged between 18-75. (5) Subjects must be informed and willing to sign an informed consent form.
Exclusion criteria
Exclusion criteria: (1) Confirmed patients with class IV angina pectoris acute myocardial infarction class IV heart failure valve heart disease cor pulmonale hypertrophic cardiomyopathy with atrial fibrillation. (2) Confirmed patients with hyperthyroidism-related atrial fibrillation or dilated cardiomyopathy with atrial fibrillation or patients with thyroid dysfunction. (3) Patients with hypotension or poorly controlled blood pressure (=160/110mmHg) or significant hemodynamic disorders. (4) Patients with severe cardiopulmonary dysfunction accompanied by severe arrhythmias (paroxysmal ventricular tachycardia supraventricular tachycardia etc.). (5) Patients with atrial fibrillation after heart valve replacement or repair surgery. (6) Patients with abnormal liver function kidney function hematopoietic system abnormalities or severe primary diseases such as mental illness. (7) Patients participating in other clinical trials. (8) Presence of any clinically significant abnormalities found during laboratory tests physical examinations and electrocardiogram examinations that may interfere with this trial's research and observation. (9) Pregnant or planning to become pregnant unable to take effective contraceptive measures or lactating women. (10) Patients contraindicated for amiodarone (severe sinoatrial node dysfunction atrioventricular block bradycardia prolonged intervals). (11) Patients allergic to any medication used in this trial. (12) Unwilling to participate in the trial or estimated poor compliance.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1-year recurrence rate of AF; | — |
Secondary
| Measure | Time frame |
|---|---|
| life quality score;Evaluation of curative effect of TCM syndrome;Indicators of inflammation;Incidence of cardioversion;Echocardiography indicators; | — |
Countries
China
Contacts
Public ContactQiulei Jia
Dongzhimen Hospital Beijing University of Chinese Medicine
Outcome results
None listed